About

About Kura Biotech Blikka Genomics, the newest division of Kura Biotech, operates in the fields of DNA sequencing and controlled enzymatic synthesis. Guided by our vision to catalyze multi-omics evolution through smart enzymatic development, and leveraging Cantera, our state-of-the-art protein engineering platform, Blikka develops high-performance products that drive scientific breakthroughs. Blikka Genomics commitment to precision, innovation, and sustainability ensures researchers have the tools they need to achieve significant advancements in precision medicine and genomics. Join us in catalyzing multi-omics evolution through smart enzymatic development.